The Psychedelic Skeptic

In this episode of The Psychedelic Skeptic, we speak with Dori Lewis and Dr. Shannon Hughes, co-founders of Elemental Psychedelics, one of Colorado's first state-approved psilocybin facilitator training programs.Key Topics:Colorado's regulated psilocybin access model following the passage of Prop 122The tension between medicalization and honoring the whole-mushroom experienceWhat to expect from a psilocybin session in a licensed healing centerThe unique approach of their facilitator training programTransitioning from underground practice to the regulated spacePricing and accessibility concerns in the regulated modelThe importance of developing a relationship with the medicine before becoming a facilitatorAbout Our Guests:Dori Lewis, MA, MEd, LPC-S, brings her expertise as a therapist and owns Reflective Healing, recently approved as Colorado's second licensed healing center. Dr. Shannon Hughes, MSW, PhD, contributed to Colorado's rulemaking process as a participant in the training and licensing subcommittee and previously researched underground practitioners as a faculty member at Colorado State University.Timestamps:00:00 - Introduction05:15 - Concerns about extractivist approaches to psilocybin08:30 - Overview of Colorado's regulated access program14:45 - What makes their facilitator training program unique18:20 - What to expect as a client seeking psilocybin services23:45 - Anticipated demand and accessibility issues28:15 - The underground community's response to regulation34:30 - Looking ahead: Milestones to watch for37:15 - What's missing from psychedelic discourse: Decolonial perspectives and drug exceptionalismResources:Elemental Psychedelics: https://www.elementalpsychedelics.com/Reflective Healing: https://www.reflectivehealing.com/Colorado Natural Medicine Health This episode was recorded in April 2025, shortly before the launch of Colorado's first licensed psilocybin healing centers.

In this episode of The Psychedelic Skeptic, Dr. Anne Metz speaks with Dr. Daniel Moseley, Assistant Professor of Bioethics at East Carolina University's Brody School of Medicine. Dr. Moseley brings his unique background spanning philosophy and psychiatry to explore the ethical dimensions of psychedelics through the lens of human enhancement.Episode Highlights:Dr. Moseley discusses his journey from philosophy to bioethics and his work on human enhancement for the Stanford Encyclopedia of PhilosophyThe distinction between therapeutic treatments versus enhancement uses of medical technologiesHow psychedelics differ from other enhancement technologies by affecting the whole person rather than specific capacitiesThe ethical debates around personal freedom versus paternalism in regulating enhancement technologiesExploration of ego dissolution experiences and different philosophical interpretationsDiscussion of the current challenges in psychedelic research, including placebo effects and exogenous factorsConcerns about how political and healthcare system changes might impact psychedelic therapiesResources Mentioned:Jonathan Lear's work on the parallels between ancient Greek ethics and psychotherapy, particularly his book "The Concept of Irony"Peter Kramer's book "Listening to Prozac"Follow Dr. Daniel Moseley's work at danieldmoseley.com and his blog "Dispatches from the Blood-Brain Barrier."The Psychedelic Skeptic is available on all major podcast platforms. For more information visit annemetz.com or follow @doctormetz on Instagram. Have a question or guest suggestion? Email [email protected].

Dr. Béalleka Makau, cultural consultant and educator, joins The Psychedelic Skeptic to discuss the critical intersection of cultural awareness, power dynamics, and psychedelic healing.As a Kenyan-born, Black queer scholar who left academia after experiencing systemic inequities, Dr. Makau shares her transformative REDE (Radical Empathy Disrupts Entitlement) framework and its adaptation for psychedelic spaces. She reveals how psychedelic experiences can either reinforce harmful dynamics or catalyze profound societal change depending on our willingness to confront uncomfortable truths.Through candid personal stories of experiencing harm in predominantly white psychedelic circles, Dr. Makau illustrates why preparation work that examines our cultural narratives and entitlement is essential before engaging with these powerful medicines. She challenges practitioners and clients alike to recognize how historical power dynamics continue to shape our relationships, and offers practical approaches to decolonizing our minds for more ethical healing work.This thought-provoking conversation explores cultural humility as more than just a supplement to psychedelic therapy but as fundamental to its ethical practice. Dr. Makau invites listeners to imagine what revolutionary change might be possible if we harness the psychedelic renaissance to dismantle oppressive systems and move toward collective liberation.To learn more about Dr. Béalleka Makau's work with Radical Empathy Disrupts Entitlement (REDE), her cultural consulting services, and her "REDE for Psychedelics" program, visit her website at www.bealleka.com. There you can explore her writing on "peculiar intimacy," learn about the Peculiar Intimacy Healing Institute (PI High), and discover 8 Star Sanctuary, her healing space inspired by the literary legacy of Octavia Butler. For organizations interested in REDE training or individuals seeking coaching on cultural literacy and liberation practices, you can reach Dr. Makau through her website to schedule a consultation.

In 2018, 22-year-old Brandon Begley lost his life after participating in ayahuasca ceremonies at SoulQuest Church in Orlando, Florida. In this powerful episode, Brandon's father John Paul Begley and attorney William Chapman discuss their successful $15 million wrongful death lawsuit against SoulQuest and its founder Chris Young. Brandon, a joyful young man passionate about music and sports, attended SoulQuest seeking spiritual growth. During his second retreat, he developed severe acute hyponatremia (low blood sodium) after combining ayahuasca ceremonies with kambo. Despite showing clear signs of medical distress, SoulQuest staff delayed calling emergency services for over three hours. Brandon passed away days later. Key revelations include: SoulQuest earned over $13 million between 2019-2020 while operating as a tax-free church The facility lacked proper medical protocols and oversight Young attempted to deflect blame by falsely claiming Brandon had concealed a medical condition Recent legal developments have forced SoulQuest's closure, though similar operations continue emerging This case raises crucial questions about safety standards and accountability in psychedelic churches. While Brandon believed in psychedelic medicine's potential, his death highlights the dangers of unregulated ceremonies and the urgent need for proper medical screening, protocols, and emergency response procedures. The episode concludes with John Paul's ongoing fight for justice and his mission to prevent similar tragedies through increased oversight of psychedelic churches. His message: "Love one another. Take care of each other." Warning: This episode contains discussion of death and medical emergencies that some listeners may find distressing.

After Matthew Perry's tragic death raised new questions about ketamine therapy, Sam Mandel, CEO of Ketamine Clinics Los Angeles, joins us to separate fact from fiction. With over 30,000 infusions administered and an 83% success rate, KCLA is at the forefront of mental health innovation. Sam breaks down: The crucial differences between recreational use and clinical treatment Why ketamine remains the fastest-acting antidepressant available How supervised infusion therapy actually works The future of ketamine alongside other psychedelic treatments Common misconceptions and stigma around ketamine therapy This episode offers a clear-eyed look at ketamine's therapeutic potential while acknowledging valid concerns about its use. Whether you're considering treatment or just curious about developments in mental health care, this conversation provides essential context from one of the field's leading voices.

In this episode of 'The Psychedelic Skeptic,' Dr. Anne Metz discusses the impact of the psychedelic renaissance on indigenous communities with Dr. Melissa Frost, a Spanish professor at the University of Virginia. They delve into the historical and contemporary use of psychoactive substances like psilocybin mushrooms and peyote, particularly focusing on the Mazatec and Wirarika communities. They also address the complexities of cultural appropriation versus cultural appreciation and the importance of indigenous reciprocity in advancing psychedelic therapy. 00:00 Introduction to the Psychedelic Skeptic 00:28 Impact of Psychedelic Renaissance on Indigenous Communities 01:42 Guest Introduction: Dr. Melissa Frost 02:32 Historical Context of Psychedelics in Colonial Mexico 10:31 Traditional Use of Psychedelics in Indigenous Communities 16:35 Modern Psychedelic Practices and Indigenous Reciprocity 33:31 Cultural Appropriation vs. Cultural Appreciation 44:24 Conclusion and Final Thoughts Learn more about Dr. Frost: https://spanitalport.as.virginia.edu/people/melissa-frost

In the second part of our conversation with Ed Prideaux, we explore the recovery process, research developments, and clinical implications of Hallucinogen Persisting Perception Disorder (HPPD). Ed shares: His personal recovery journey and coping strategies The importance of accepting the reality of one's condition The potential pitfalls of online HPPD communities Current research on HPPD, including studies on different psychedelics The need for better diagnostic criteria and understanding among clinicians The relationship between HPPD and other visual disorders like Visual Snow Syndrome Insights on how therapists can better support individuals with HPPD Ed also discusses the broader implications of HPPD in the context of increasing psychedelic use and legalization. This episode provides valuable information for clinicians, researchers, and anyone interested in the potential risks associated with psychedelic use.

In this eye-opening first part of our conversation with Ed Prideaux, we explore the world of Hallucinogen Persisting Perception Disorder (HPPD). Ed, a researcher and someone who has personally experienced HPPD, provides a comprehensive explanation of this rare condition that can occur after psychedelic use. He discusses: The definition and symptoms of HPPD His personal journey with the condition The varying degrees of HPPD severity, from mild to debilitating The potential link between adolescent psychedelic use and HPPD The challenges of diagnosis and self-diagnosis The intersection of HPPD with other conditions like depersonalization and derealization Ed offers valuable insights into the complexities of HPPD, shedding light on a condition that is often misunderstood or overlooked in discussions about psychedelic use. Listener discretion advised.

In this episode of *The Psychedelic Skeptic*, Dr. Anne Metz dives into the world of psychedelic churches with guest Sean McAllister. Sean, an attorney based in Colorado, has dedicated nearly 25 years to drug policy reform, making significant strides in the legal recognition of psychedelic practices. Join us as Sean shares his journey from cannabis legalization to defending the Church of the Eagle and Condor in a landmark case. Discover the intricacies of religious freedom law, the potential of psychedelic churches for broader accessibility, and the challenges these communities face within the legal framework. We also explore the critical role of sincerity in religious practices, the definition of a church in the eyes of the law, and how these evolving legal landscapes can influence the future of psychedelics. Tune in for a conversation that not only highlights the victories in this movement but also addresses the skepticism and challenges that lie ahead. For more about Sean McAllister, visit McAllisterLawOffice.com and follow Dr. Anne Metz on Instagram @doctormetz.

Dr. Anne Metz, a licensed and skeptical psychedelic therapist, dives into the intricacies of the Oregon Psilocybin Services Act with her guest Dr. Ryan Reese from Oregon State University. They discuss the requirements and training for becoming a licensed psilocybin facilitator, potential adverse experiences, and the accessibility of psilocybin services. Dr. Reese shares his process for client preparation, dosing, and integration, emphasizes the importance of a holistic support system, and highlights the challenges and nuances of this growing field. The conversation also touches on broader implications for mental health and the integration of eco wellness into therapeutic practices. https://www.questtherapeuticsinc.com/

In this episode of The Psychedelic Skeptic, host Dr. Anne Metz sits down with Paul Miller, aka DJ Spooky, to explore the intersection of psychedelics, music, and environmental activism. Paul shares his journey from DJing in Antarctica to becoming a vocal advocate for climate literacy through the arts. The conversation meanders through the role of psychedelics in addressing the climate crisis, Paul's experiences with outdoor adventures, and his deep thoughts on the cultural and psychological impacts of music, art, and technology on society. Anne and Paul delve into the intricacies of psychedelics as tools for critical thinking, their potential in therapy, and the cultural significance of musical genres. This insightful discussion not only shines a light on Paul's multifaceted career but also invites listeners to consider the broader implications of psychedelics on environmental awareness and creative expression.   PSYCA event in NYC https://www.facebook.com/events/1647888475962624/  Psychedelics for Climate Action (PSYCA) https://www.psyca.org/

In this episode of the Psychedelic Skeptic, Dr. Anne Metz dives deep into the world of psilocybin-assisted therapy retreats with Justin Townsend, CEO of MycoMeditations in Jamaica. MycoMeditations is one of the most established and respected psilocybin retreat centers, known for their high-dose protocols and impressive results in treating depression, PTSD, anxiety and more. Justin shares fascinating insights into the intensive therapeutic processes that take place during their retreats. He discusses their rigorous facilitator training program, extensive safety measures, and the profound experiences guests undergo as they navigate powerful catharsis and emotional healing. While acknowledging the challenges and risks involved, Justin argues for the transformative potential of skilfully administered psilocybin journeys in a carefully designed setting. He emphasizes the importance of the authentic relationship between facilitator and guest, predicting high demand for psychedelic therapy as it becomes more accessible. MycoMeditations.com

Join us as we explore the controversial world of psychedelic churches and the legal battles they face, focusing on the Church of Ambrosia and its founder, Dave Hodges. We'll discuss the church's use of psilocybin mushrooms as a sacrament, the ongoing fight for legalization, and the complex issues surrounding religious freedom and drug policy. Stay tuned for an exclusive upcoming interview with Sean McAllister, lead counsel for the Church of the Eagle and Condor, who recently won the right to import ayahuasca for religious purposes. https://www.sfchronicle.com/bayarea/article/church-of-ambrosia-magic-mushroom-19372526.php

In this episode of The Psychedelic Skeptic, Dr. Anne Metz explores the newly proposed regulations for Colorado's upcoming legal psilocybin services program. She delves into the challenges and potential benefits of becoming a certified psilocybin facilitator in Colorado, highlighting the impact on mental health professionals and the accessibility of psychedelic therapy. Join Dr. Metz and Psychedelic Spaceman as they discuss the implications of these regulations and share their insights on the evolving landscape of psychedelic therapy.

So why the psychedelic skeptic? Well, skeptics play an essential role in any discussion surrounding psychedelics. While there are those who embrace the potential benefits and transformative experiences that psychedelics offer, there are also skeptics who approach these substances with caution and skepticism. They raise valid concerns and questions that deserve to be explored and addressed.

Note to listeners, I remixed this episode to include our new theme music by Wes Swing. Dr. Rachel Harris, author of 'Swimming in the Sacred,' discusses her research on underground guides and the importance of their wisdom in the field of psychedelics. She distinguishes between ceremonial work and research, highlighting the transformative focus of the former. Dr. Harris emphasizes the need for researchers to consult experts and learn from the experiences of underground guides. She explores the historical context of the psychedelic underground and the challenge of holding these medicines in the modern world. The conversation also delves into the role of gender, the importance of personal work, and the future of psychedelics and integration. Takeaways Underground guides offer a unique perspective on psychedelics, focusing on transformation and spiritual development rather than diagnoses and symptom reduction. Researchers should consult underground guides and experts to inform their studies and design appropriate research methodologies. The psychedelic underground has a rich historical context, and it is important to consider how these medicines have been held in sacred ways in indigenous cultures for centuries. Personal work and training are crucial for therapists and guides working with psychedelics, and therapists should have their own therapy experiences to better understand the psychedelic journey. The future of psychedelics requires careful consideration of how these medicines are held and integrated into different contexts, including therapeutic, ceremonial, and personal growth settings.

Dr. Katherine MacLean, a neuroscientist and expert in the effects of mindfulness meditation and psychedelics, discusses the future of psychedelics, addressing inequity and lack of access, preventing abuse in psychedelic therapy, navigating spiritual and recreational use, informed consent and risks, and the role of gender dynamics in psychedelic work. The conversation explores the importance of community-oriented healing environments. It also delves into the topic of gender in psychedelic therapy and the need for education on psychedelics for young people. https://www.katherinemaclean.org/ Takeaways Greater access to MDMA therapy for PTSD can help improve mental health, but broader access beyond FDA-approved treatments is important. Psychedelics have the potential to enhance mental health and emotional well-being in healthy individuals, not just those with diagnoses. Creating safe spaces and involving multiple guides or loved ones can help prevent abuse and ensure a supportive environment during psychedelic experiences. Informed consent is crucial, and individuals should be aware of the potential risks and benefits of psychedelic experiences. Psychedelics can open up spiritual experiences and perspectives, and individuals should be prepared for the potential impact on their beliefs and worldview. Gender dynamics have played a role in the history of psychedelic work, and it is important to consider the experiences and perspectives of women in the field. Women are naturally inclined to hold multiple roles and responsibilities, making them well-suited for the complex work of psychedelic therapy. Psychedelic therapy is best conducted in a community-oriented healing environment, where the pressure on any one individual or relationship is reduced. Gender should not be the sole determining factor in choosing a psychedelic guide, but rather the focus should be on creating a supportive and inclusive environment. There is a need for better education on psychedelics for young people to ensure they have a comprehensive understanding of the risks and benefits.

This week's guest is Dr. Elizabeth Nielson. Dr. Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson was a Site Co-Principal Investigator and therapist for an FDA-approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder. She has also served as a therapist on FDA-approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, psilocybin-assisted treatment of treatment-resistant depression, and earlier phase 2 and 3 trials of MDMA-assisted psychotherapy. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in the integration of psychedelic experiences in clinical settings.

Hey everyone! I'm trying out a new format for the show. Let me know what you think. [email protected] Dr. Scott Shannon, a psychiatrist with a background in consciousness studies and holistic mental health, discusses various topics related to psychedelics and mental health. He shares his early interest in consciousness and psychedelics, compares the limitations of SSRIs and psychedelics, and explores different paradigms in mental health. Dr. Shannon also discusses the role of the inner healing intelligence and the current societal context in the use of psychedelics. He emphasizes the individual response to psychedelics and the need for comprehensive support systems in mental health care. TLDL: Psychedelics offer a transformative approach to mental health by honoring the healing power of the psyche. The diagnostic system in psychiatry is limited and does not capture the complexity of mental health conditions. Psychedelics are not a cure-all and should be used as part of a comprehensive system of support and treatment. The FDA approval process for psychedelics is ongoing, with MDMA likely to receive approval in the next few years. Microdosing psychedelics has risks and limited evidence of benefits, and caution should be exercised in its use.

Our guest today was Alleged to have produced "90% of the world's LSD," William Leonard Pickard is a former drug policy fellow at Harvard's Kennedy School of Government, research associate in neurobiology at Harvard Medical School, and deputy director of the Drug Policy Analysis Program at UCLA. With two life sentences without parole, he served 20 years in maximum security federal prisons, and was released in 2020. Currently, he is a senior advisor for JLS Fund II LP and the Fireside Project. He is a research affiliate with Harvard Law School, Petrie-Flom Center on Health Law Policy, Biotechnology and Bioethics, Program on Law and Regulation.

In this inaugural episode of "Psychedelic Skeptic," we dive deep into the fascinating intersection of philosophy, skepticism, and the rapidly evolving world of psychedelic therapy. Our charming guest, Dr. Matthew Adams, a renowned philosophy professor from Indiana University, guides us through the intellectual tradition of skepticism and why it might be more crucial than ever as psychedelics gain recognition as a legitimate treatment for mental health issues. https://www.matthewadamsphilosophy.net/

Thank you for tuning in to this introductory episode of our podcast. Make sure to subscribe, as we have many exciting conversations lined up with experts and pioneers in the field. Stay curious, stay open-minded, and let's dive headfirst into the wonderful world of psychedelics.